PRGO vs XRAY

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 11, 2026

PRGO

29.6
AI Score
VS
XRAY Wins

XRAY

51.6
AI Score

Investment Advisor Scores

PRGO

30score
Recommendation
SELL

XRAY

52score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric PRGO XRAY Winner
Forward P/E 6.2854 7.1124 PRGO
PEG Ratio 1.1418 0.7113 XRAY
Revenue Growth -3.2% -4.1% PRGO
Earnings Growth -63.6% 15.2% XRAY
Tradestie Score 29.6/100 51.6/100 XRAY
Profit Margin -41.9% -15.0% XRAY
Beta 1.00 1.00 Tie
AI Recommendation SELL HOLD XRAY

Relative Price Performance (Last 90 Days)

PRGO 1M: +7.6% · 3M: +25.3% XRAY 1M: -8.3% · 3M: +3.2%

Current Technical Phase

PRGO

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (13.6% over 20 days), RSI 51

RSI (14): 51.3 · Price: $13.66

XRAY

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 36

RSI (14): 35.7 · Price: $10.46

Fundamentals Snapshot

Metric PRGO XRAY
Market Cap
Forward P/E 5.7 6.9
Trailing P/E
Revenue (TTM)
Revenue Growth 0.0% 0.0%
Gross Margin 0.3% 0.5%
Operating Margin 0.0% 0.1%
EPS -11.65 -2.68
Dividend Yield 0.08% 0.03%

Frequently Asked Questions

Based on our detailed analysis, XRAY is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.